1. Home
  2. Labeler Index
  3. Xellia Pharmaceuticals Usa Llc
  4. 70594-023
  5. NDC Package Code: 70594-023-09 Colistimethate

NDC Package 70594-023-09 Colistimethate

Colistimethate Sodium Injection, Powder, For Solution Intramuscular; Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70594-023-09
Package Description:
1 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Product Code:
70594-023
Proprietary Name:
Colistimethate
Non-Proprietary Name:
Colistimethate Sodium
Substance Name:
Colistimethate Sodium
Usage Information:
Colistimethate is an antibiotic used to treat certain bacterial infections. It works by stopping the growth of bacteria.
11-Digit NDC Billing Format:
70594002309
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1117522 - colistin 75 MG/ML Injectable Solution
  • RxCUI: 1117522 - colistin (as colistimethate sodium) 75 MG/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Xellia Pharmaceuticals Usa Llc
    Dosage Form:
    Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • COLISTIMETHATE SODIUM 150 mg/1
  • COLISTIMETHATE SODIUM 150 mg/1
    • Pharmacologic Class(es):
  • Polymyxin-class Antibacterial - [EPC] (Established Pharmacologic Class)
  • Polymyxins - [CS]
  • Polymyxin-class Antibacterial - [EPC] (Established Pharmacologic Class)
  • Polymyxins - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA205356
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-01-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 70594-023-09 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    70594002309J0770Colistimethate sodium injUP TO 150 MG1111

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    70594-023-011 VIAL, GLASS in 1 VIAL / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS
    70594-023-0412 VIAL, GLASS in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70594-023-09?

    The NDC Packaged Code 70594-023-09 is assigned to a package of 1 vial in 1 carton / 1 injection, powder, for solution in 1 vial of Colistimethate, a human prescription drug labeled by Xellia Pharmaceuticals Usa Llc. The product's dosage form is injection, powder, for solution and is administered via intramuscular; intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 70594-023 included in the NDC Directory?

    Yes, Colistimethate with product code 70594-023 is active and included in the NDC Directory. The product was first marketed by Xellia Pharmaceuticals Usa Llc on October 01, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 70594-023-09?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 70594-023-09?

    The 11-digit format is 70594002309. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270594-023-095-4-270594-0023-09